Blockade of ADORA1 using an antagonist or genetic knockout protects against ethanol-induced fatty liver or alpha-naphthyl isothiocyanate-induced intrahepatic cholestatic liver injury (Peng et al. 2009; Yang et al. 2013). Here, ADORA1 is linked to medical procedure.